The Pathogenesis of Pulmonary Sarcoidosis and Implications for Treatment
Abstract
No abstract availableKeywords
This publication has 85 references indexed in Scilit:
- Refractory Pulmonary SarcoidosisClinical Pulmonary Medicine, 2016
- Designing peptidic inhibitors of serum amyloid A aggregation processAmino Acids, 2016
- Oral Antimycobacterial Therapy in Chronic Cutaneous SarcoidosisJAMA Dermatology, 2013
- IFN‐γ and IL‐12 synergize to convert in vivo generated Th17 into Th1/Th17 cellsEuropean Journal of Immunology, 2010
- T Cell Responses to Mycobacterial Catalase-Peroxidase Profile a Pathogenic Antigen in Systemic SarcoidosisThe Journal of Immunology, 2008
- Sustained IL-12 Signaling Is Required for Th1 DevelopmentThe Journal of Immunology, 2004
- ATS/ERS/WASOG statement on sarcoidosisEuropean Respiratory Journal, 1999
- Anti-Inflammatory Cytokine Release by Alveolar Macrophages in Pulmonary SarcoidosisAmerican Journal of Respiratory and Critical Care Medicine, 1996
- Inflammatory granuloma formation is mediated by TNF-alpha-inducible intercellular adhesion molecule-1.The Journal of Immunology, 1994
- The Impact of Smoking on Mechanical Properties of the Lungs in Idiopathic Pulmonary Fibrosis and SarcoidosisAmerican Review of Respiratory Disease, 1991